Le Lézard
Classified in: Health, Business
Subjects: LIC, PET, ANW

YuMOVE Explains the Importance of Triple Action Joint Support for Dogs


ORLANDO, Fla., June 1, 2023 /PRNewswire/ -- YuMOVE, a high-quality joint supplement for dogs and the American Kennel Club's official dog joint supplement, offers triple-action formula to ease occasional stiffness, support joint structure and promote mobility in dogs.

Scientific understanding of canine mobility concerns and support has greatly advanced in recent years, making it the right time for pet owners to re-evaluate and rethink joint supplements as part of an effective, multi-modal care plan. 

YuMOVE is scientifically proven to work in six weeks1. YuMOVE joint care is based on more than 15 years of scientific research. So, what makes YuMOVE different?

YuMOVE, the UK's #1 veterinary hip and joint supplement brand3, already supports two million+ dogs a year globally4. For years, YuMOVE has been providing a high-quality dog hip and joint supplement that's scientifically proven to work in just six weeks1. There's also a six-week Money-Back Guarantee5, if not satisfied. 

See the Difference 
YuMOVE is offering 30% off any YuMOVE hip and joint supplement for dogs using the code "YuMOVEMENT" for a one-time purchase.  

Learn more: YuMOVE. Read what customers are saying: Trustpilot. Watch YuMOVE's latest commercial: YuMOVE: We're Obsessed with Dogs.

Footnotes  
1  YuMOVE Joint Care is scientifically proven to work in 6 weeks by an in vivo, double blind, placebo-controlled, objectively measured canine clinical study by Royal Veterinary College UK (excludes YuMOVE for Young Dogs). 
2  Balogh?et al, J?Agric Food Chem. 2008 Nov 26;56(22):10582-93. 
3  Kynetec VetTrak January 2023. Sales of YuMOVE branded joint products through veterinary wholesalers. 
4  YuMOVE brand tracking study 2022. 
5  For full terms/conditions see yumove.com/guarantee. 

Media Contact 
Phillip Sontag 
917.446.4123
[email protected]

SOURCE YuMOVE


These press releases may also interest you

at 06:05
Rockwell Medical, Inc. (the "Company") , a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the...

at 06:05
Organigram Holdings Inc. , (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the second quarter ended March 31, 2024 ("Q2 Fiscal 2024"). "We are pleased with our performance against the strategic...

at 06:05
Hudbay Minerals Inc. ("Hudbay" or the "company") today released its first quarter 2024 financial results. All amounts are in U.S. dollars, unless otherwise noted. All production and cost amounts reflect the Copper Mountain mine on a 100% basis, with...

at 06:05
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing Agreement with Norgine to Commercialize PEDMARQSItm...

at 06:00
Titan Mining Corporation  ("Titan" or the "Company") announces the results for the quarter ended March 31, 2024. (All amounts are in U.S. dollars unless otherwise stated) Don Taylor, President and Chief Executive Officer of Titan, commented,...

at 06:00
Centerra Gold Inc. ("Centerra" or the "Company") today reported its first quarter 2024 operating and financial...



News published on and distributed by: